Randomized clinical trial on the efficacy and safety of perioperative management using ERAS protocol in gastric cancer

Randomized clinical trial on the efficacy and safety of perioperative management using ERAS protocol in gastric cancer - Randomized clinical trial on perioperative management using ERAS(Enhanced recovery after surgery) protocol in gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011572

Enrollment

140

Registered

2013-08-24

Start date

2013-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Shortened fasting period Early oral intake Omission of bowel preparation Oral prophylactic analgesic Conventional fasting period Conventional oral intake bowel preparation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with radical surgery is scheduled. 2)ASA(American Society of Anesthesiology)class 1-3. 3)T factor T1a-T4a. 4)Weight loss rate the month prior to surgery is within 10%. 5)Written informed consent must be obtained from patients.

Exclusion criteria

Exclusion criteria: 1)Patients with severe complications. 2)Requiring resection the other organs except the gallbladder. 3)Patients with infection in progress. 4)Emergency surgery. 5)Patients with uncontrolled diabetes. 6)Patients enrollment to the study is determined to be inappropriate.

Design outcomes

Primary

Measure	Time frame
Postoperative lengths of stay	—

Secondary

Measure	Time frame
Postoperative complication rate Readmission rate Mortality rate Weight loss rate	—

Countries

Japan

Contacts

Public ContactRyo Tanaka

Osaka medical college General and Gastroenterological Surgery

sur148@poh.osaka-med.ac.jp072-684-6263

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026